Myriam R. Lorenz
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiation.
Journal: Journal of human immunity
Published: November 06, 2025
Somatic STAT5BN642H mutations shape variable immune landscapes resulting in heterogenous immune diseases.
Journal: The Journal of allergy and clinical immunology
Published: September 09, 2025
Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti.
Journal: Journal of clinical immunology
Published: February 01, 2024
Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
Journal: The Journal of allergy and clinical immunology
Published: September 21, 2023
Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study.
Journal: The Lancet. Haematology
Published: July 08, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation.
Journal: The Journal of experimental medicine
Published: May 29, 2023
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Journal: The Journal of allergy and clinical immunology
Published: March 23, 2023
Hematologically important mutations: Leukocyte adhesion deficiency (second update).
Journal: Blood cells, molecules & diseases
Published: October 29, 2022
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 15, 2022
Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations.
Journal: The Journal of allergy and clinical immunology
Published: August 11, 2022
The Growing Spectrum of DADA2 Manifestations-Diagnostic and Therapeutic Challenges Revisited.
Journal: Frontiers in pediatrics
Published: February 28, 2022
Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.
Journal: EMBO molecular medicine
Published: July 26, 2021
Last Updated: 09/26/2026